Goodwin Investment Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-98
Closed -$8.8K 230
2022
Q2
$8.8K Sell
98
-429
-81% -$43.5K 0.01% 117
2022
Q1
$58K Sell
527
-14
-3% -$1.48K 0.04% 73
2021
Q4
$56K Buy
541
+60
+12% +$6.95K 0.04% 72
2021
Q3
$60K Buy
+481
New +$62.3K 0.06% 60
2021
Q2
Sell
-481
Closed -$57K 138
2021
Q1
$57K Buy
+481
New +$56.4K 0.07% 58

Other funds holding MDT

Goodwin Investment Advisory's MDT Position: Q3 2022 in Review

Goodwin Investment Advisory sold out of Medtronic (MDT) in Q3 2022, closing a stake of 98 shares — an estimated $8.8K sold.

Goodwin Investment Advisory first reported a position in MDT in Q1 2021 and held it in 5 quarters. The position peaked at $60K in Q3 2021. 1,932 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Goodwin Investment Advisory reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Goodwin Investment Advisory sold 98 Medtronic shares in Q3 2022, an estimated $8.8K.
  • Goodwin Investment Advisory first reported a position in Medtronic in Q1 2021 and held it in 5 quarters.
  • Goodwin Investment Advisory's Medtronic position peaked at $60K in Q3 2021.
  • 1,932 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Goodwin Investment Advisory's 13F filing for Q3 2022, filed 14 Nov 2022.